Physician
Dermatology
Dr. Ivor Caro, MD
|
|
Give Review
Ivor Caro, MD is an expert in the field of Dermatology. Ivor Caro, MD is a published doctor. He has 34 papers published. The most current publication "Keratoacanthoma in a Bantu child."
Publications
- The aging face. Why changes occur, how to correct them.
- Does electronic implementation of questionnaires used in asthma alter responses compared to paper implementation?
- Lipoid proteinosis.
- Keratoacanthoma in a Bantu child.
- Scar sarcoidosis.
- Familial lichen planus.
- Intrauterine herpes simplex infections.
- Shortage of full-time faculty in dermatology.
- Reticulate acropigmentation of Kitamura.
- Secondary cutaneous mucinosis with systemic lupus erythematosus. A case presentation and review of the literature.
- Discoloration of the teeth related to minocycline therapy for acne.
- Leucomelanoderma in blacks. A recent epidemic.
- Multicenter clinical evaluation of ketoconazole in the treatment of cutaneous fungal infections.
- T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action.
- Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis.
- Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened.
- The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment.
- Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.
- Subcutaneous efalizumab is not effective in the treatment of alopecia areata.
- Efalizumab for the treatment of psoriatic arthritis.
- Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial.
- Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. part II.
- Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
- Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.
- Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience.
- Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
- Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
- Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
- Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis.
- Clinical benefits in patients with psoriasis after efalizumab therapy: clinical trials versus practice.
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
- Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy.
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-2003 - a 16-year-old girl with a rash and chest pain.
Doctors Specialties
- Dermatology
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. James C. Barton, MD |
|
|
Dr. Thomas J. Morris, MD |
|
|
Dr. David R. Murad Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul S. Kwon, MD
This Doctor is OpenDoctor Recommended.
|